TZM GmbH

TZM GmbH specializes in the UMG, a medical device designed for monitoring and recording physiological signals such as electrocardiograms (ECG), blood pressure, and other vital parameters. This device is primarily used in clinical and research settings, including hospitals, laboratories, and intensive care units, to aid in patient diagnostics and continuous monitoring.

TZM GmbH is based in Germany, operating from a location within the country. The company’s headquarters or primary operational address is located in DE, as indicated by its registration details.

TZM GmbH’s devices, including the UMG, are listed in the eudamed database, which is the EU’s central registry for medical devices. This registration ensures traceability and compliance with EU regulatory requirements, particularly under the Medical Device Regulation (MDR).

The UMG falls under Class IIb classification in the EU’s medical device regulatory framework. This classification is assigned based on the device’s intended purpose and associated risks, requiring compliance with stricter regulatory controls, such as clinical evaluations and conformity assessments, to ensure safety and performance.